Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528

Clinical trial NCT01536574 · COMPLETED

Trial details

NCT number: NCT01536574
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2010-09-02
Primary completion: 2012-03-01
Enrollment: 295

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.